It is widely known that mega-dose vitamin C transiently produces hydrogen peroxide, an oxidant, to selectively kill cancer cells. In the late 1970s Linus Pauling and Ewan Cameron were first to report of success utilizing intravenous vitamin C to produce 1-year survival among 22 percent of otherwise hopeless cancer patients (chemotherapy at the time was far less effective). Subsequent studies concluded oral vitamin C could not possibly reach adequate blood concentrations of vitamin C to produce hydrogen peroxide (cancer cell killing effect) even though the data from that study ran contrary to the conclusions drawn. [Knowledge of Health 2016]
Thereafter Steve Hickey and Hilary Roberts posited a dynamic flow theory of ascorbate (vitamin C) therapy that addressed the fact vitamin C is rapidly excreted and its oral absorption is drastically reduced when consumed in mega-doses. Therefore, Hickey and Roberts posed intermittent oral administration of vitamin C to maintain high blood levels sufficient to exert a cell killing (cytotoxic) effect in cancer cells. [Journal Orthomolecular Medicine Vol. 20, 2005] Liposomal vitamin C further increases vitamin C delivery inside cells to potentially effect a cure.
Curing the Incurable: …
Best Price: $12.68
Buy New $20.99
(as of 12:20 EST – Details)
These revelations have led to a renaissance in the use of vitamin C for cancer. [Knowledge of Health, 2016]
Now another breakthrough in the scientific understanding of vitamin C therapy for cancer is being reported. Researchers in Japan report extracellular iron (outside cancer cells) decomposes hydrogen peroxide generated by vitamin C. The inhibition of cancer cell growth via vitamin C (hydrogen peroxide) is…